Mrs. Swarna Malhotra has filed a regulatory disclosure under SEBI takeover regulations following her acquisition of equity shares in Sunshield Chemicals Limited. The latest filing dated March 2, 2026, details the purchase of 100 equity shares through open market operations on February 27, 2026.

Latest Acquisition Details

The disclosure filed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 provides comprehensive details of the recent share acquisition:

Current Shareholding Pattern

The filing reveals the detailed shareholding structure of Mrs. Malhotra and her Persons Acting in Concert (PAC) before and after the latest transaction:

Before Latest Acquisition:

After Latest Acquisition:

Persons Acting in Concert

The disclosure identifies the following entities as Persons Acting in Concert with Mrs. Swarna Malhotra:

• Indus Petrochem Limited
• Coppersmith Energies and Project Private Limited
• Sudhir Malhotra

The group collectively belongs to the promoter category and maintains significant control over Sunshield Chemicals Limited.

Company Share Capital

The equity share capital of Sunshield Chemicals Limited remains unchanged at Rs. 8,79,48,360 both before and after this acquisition. The company's shares are listed on BSE Limited.

Regulatory Compliance

The acquisition has been properly disclosed in accordance with SEBI regulations, with Mrs. Malhotra filing the required documentation on March 2, 2026. The disclosure confirms that no encumbrances, warrants, or convertible securities were involved in this transaction, and no voting rights were acquired through instruments other than equity shares.

Sunshield Chemicals has announced its unaudited financial results for the quarter and nine months ended December 31, 2025, demonstrating robust performance with significant growth in profitability. The company's Board of Directors approved these results at their meeting held on February 3, 2026, with statutory auditors issuing an unmodified review report.

Q3FY26 Financial Performance

The company delivered strong third-quarter results with substantial improvement across key financial metrics. Revenue from operations and net profit both showed impressive year-over-year growth, reflecting enhanced operational efficiency.

Nine-Month Performance Highlights

The nine-month period ending December 31, 2025, showcased consistent growth momentum with strong improvements in both revenue and profitability metrics compared to the corresponding period in the previous year.

Rights Issue and Capital Enhancement

During the quarter ended December 2025, Sunshield Chemicals successfully completed a Rights Issue of 14,41,776 fully paid-up equity shares of face value ₹10 each at ₹901 per share, aggregating to ₹12,990.40 lakhs. The shares were allotted on October 27, 2025, with proceeds fully utilized for debt repayment and general corporate purposes by December 31, 2025.

Operational Efficiency and Cost Management

The company demonstrated improved cost management with total expenses rising to ₹30,848 lakhs for nine months compared to ₹24,724 lakhs in the previous year. Despite higher absolute costs due to business expansion, the company maintained strong profit margins through operational efficiency improvements.